[HTML][HTML] Epidemiology, mechanisms of resistance and treatment algorithm for infections due to carbapenem-resistant gram-negative bacteria: an expert panel opinion

N Coppola, AE Maraolo, L Onorato, R Scotto, F Calò… - Antibiotics, 2022 - mdpi.com
Antimicrobial resistance represents a serious threat for global health, causing an
unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in …

[HTML][HTML] Treatment Strategies of Colistin Resistance Acinetobacter baumannii Infections

A Papazachariou, RN Tziolos, S Karakonstantis… - Antibiotics, 2024 - mdpi.com
Acinetobacter baumannii has emerged as a pressing challenge in clinical practice, mainly
due to the development of resistance to multiple antibiotics, including colistin, one of the last …

[HTML][HTML] Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection

Z Zheng, Z Shao, L Lu, S Tang, K Shi, F Gong… - BMC Infectious …, 2023 - Springer
Background The rapid global emergence and spread of carbapenem-resistant Gram-
negative bacilli (CR-GNB) is recognized as a major public health concern, and there are …

[HTML][HTML] Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study

R Sirijatuphat, S Thawornkaew, D Ruangkriengsin… - Antibiotics, 2022 - mdpi.com
The in vitro study of sitafloxacin against carbapenem-resistant (CR) Acinetobacter
baumannii demonstrated activity against most strains of CR A. baumannii, and the …

[HTML][HTML] Moving toward Extensively Drug-Resistant: Four-Year Antimicrobial Resistance Trends of Acinetobacter baumannii from the Largest Department of Internal …

Y Jalali, A Liptáková, M Jalali, J Payer - Antibiotics, 2023 - mdpi.com
A. baumannii imposes a great burden on medical systems worldwide. Surveillance of trends
of antibiotic resistance provides a great deal of information needed for antimicrobial …

Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in …

M Güran, K Çakıral, K Teralı, T Kandemir… - Pathogens and …, 2023 - academic.oup.com
Several studies have demonstrated that the effectiveness of carbapenems against drug-
resistant Acinetobacter baumannii infections has been decreasing. Combination therapy …

[HTML][HTML] Tackling Acinetobacter baumannii

G Granata, F Taglietti, N Petrosillo - Journal of Clinical Medicine, 2023 - mdpi.com
Globally, multidrug-resistant (MDR) bacteria represent a menace to public health. Recently,
the World Health Organization recognized the ubiquitous, non-fermenting, rodshaped Gram …

[HTML][HTML] Gram Negatives and Antimicrobial Resistance: Two Faces of the Same Coin

N Petrosillo, G Granata - Journal of Clinical Medicine, 2022 - mdpi.com
The evolution, emergence and spread of bacterial antimicrobial resistance (AMR) represent
threatening healthcare concerns of worldwide proportions. Resistance to antimicrobials …

Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant …

C Huang, I Chen, T Tang - Journal of Clinical Medicine, 2022 - mdpi.com
Background: Open Access Reply Reply to Daitch et al. Comment on “Huang et al. Colistin
Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of …

Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii

S Huws, P Alexander, L Oyama, H Olleik, F Santos… - 2024 - researchsquare.com
Acinetobacter baumannii is recognised as a priority 1 critically important pathogen by the
World Health Organisation. The cow rumen has previously yielded antimicrobial peptides …